Pelthos Therapeutics Inc (PTHS) insider trading
Every open-market stock purchase and sale by Pelthos Therapeutics Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Peter Greenleaf (Director) and 2 others sold $55.9K in the last 90 days.
- Last insider buy: Todd C Davis (Director), $986K, 4 months ago.
Last 12 months: insiders bought $1M (1 buy) and sold $385K (10 sales). Last close $27.16 on Jul 9, 2026.
Recent PTHS insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jul 2, 2026 | Peter Greenleaf (Director) | Sold | $18.5K |
| Jul 2, 2026 | Matthew Pauls (Director) | Sold | $18K |
| Jul 2, 2026 | Ezra M Friedberg (Director) | Sold | $13.9K |
| Jul 2, 2026 | Matthew Pauls (Director) | Sold | $2.6K |
| Jul 2, 2026 | Peter Greenleaf (Director) | Sold | $2.3K |
| Jul 2, 2026 | Ezra M Friedberg (Director) | Sold | $656 |
| Jun 15, 2026 | Ezra M Friedberg (Director) | Sold | $6.1K |
| Jun 15, 2026 | Ezra M Friedberg (Director) | Sold | $1.6K |
| Jun 11, 2026 | Todd C Davis (Director) | Bought | $986K |
| Jun 11, 2026 | Todd C Davis (Director) | Bought | $14.4K |
| May 22, 2026 | Knuettel Francis II (CFO) | Bought (not open market) | $803K |
| May 22, 2026 | Knuettel Francis II (CFO) | Sold (not open market) | $574K |
| May 22, 2026 | Knuettel Francis II (CFO) | Sold | $40.3K |
| May 22, 2026 | Knuettel Francis II (CFO) | Sold (not open market) | — |
| May 14, 2026 | Ezra M Friedberg (Director) | Sold (not open market) | $3.9K |
| Apr 2, 2026 | Peter Greenleaf (Director) | Sold | $8.6K |
| Apr 2, 2026 | Matthew Pauls (Director) | Sold | $8.5K |
| Apr 2, 2026 | Peter Greenleaf (Director) | Sold | $8.1K |
| Apr 2, 2026 | Matthew Pauls (Director) | Sold | $7.9K |
| Apr 2, 2026 | Richard Malamut (Director) | Sold | $6.4K |
| Apr 2, 2026 | Ezra M Friedberg (Director) | Sold | $6K |
| Apr 2, 2026 | Richard Malamut (Director) | Sold | $6K |
| Apr 2, 2026 | Ezra M Friedberg (Director) | Sold | $5.7K |
| Dec 23, 2025 | Andrew J. Einhorn (Director) | Bought (not open market) | — |
| Dec 17, 2025 | Ligand Pharmaceuticals Inc (Insider) | Sold (not open market) | $9M |
Who's trading PTHS
- Matthew Pauls, Director: sold $37K (4 sales), last Jul 2, 2026
- Ezra M Friedberg, Director: sold $258K (9 sales), last Jul 2, 2026
- Peter Greenleaf, Director: sold $37.5K (4 sales), last Jul 2, 2026
- Todd C Davis, Director: bought $1M (2 buys), last Jun 11, 2026
- Knuettel Francis II, CFO: sold $40.3K (1 sale), last May 22, 2026
- Richard Malamut, Director: sold $12.3K (2 sales), last Apr 2, 2026
- Andrew J. Einhorn, Director: other filings, last Dec 23, 2025
- Ligand Pharmaceuticals Inc, Insider: other filings, last Dec 17, 2025
Get free alerts when an insider at Pelthos Therapeutics Inc files a new trade →